Detalles de la búsqueda
1.
Long-term data from a phase 3 study of radotinib versus imatinib in patients with newly diagnosed, chronic myeloid leukaemia in the chronic phase (RERISE).
Br J Haematol;
189(2): 303-312, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32012231
2.
Longer Hydroxyurea Administration Prior to Imatinib Mesylate is Risk Factor for Unsuccessful Major Molecular Response in Chronic-Phase Chronic Myeloid Leukemia: Possibility of P-Glycoprotein Role.
Asian Pac J Cancer Prev;
20(12): 3689-3695, 2019 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31870110
Resultados
1 -
2
de 2
1
Próxima >
>>